IN CONSERVATION: DR. JEFF STROVEL, CEO of VERALOX THERAPEUTICS

Published on :

IN CONSERVATION: DR. JEFF STROVEL, CEO of VERALOX THERAPEUTICS Veralox Therapeutics is a startup currently headquartered at the Frederick Innovation  Technology Center, Inc. (FITCI) in Frederick, Maryland. As a small molecule therapeutics company focused on developing medicines targeting the arachidonic acid pathway, they have two drug products in development for the treatment of a rare [….]

In Conversation: Sean Kirk, Emergent BioSolutions

Published on :

In Conversation: Sean Kirk, Emergent BioSolutions Following up on the recent article Two Maryland Biotechs Partner to Bring Coronavirus/COVID-19 Vaccine Candidate into Clinical Trials, BioBuzz had the opportunity to speak with Emergent BioSolutions Executive Vice President, Manufacturing and Technical Operations, Sean Kirk. Let’s start by having you provide a brief background on your role at [….]

WIB-Capital Region: Member Spotlight with Julie (Wu) Rosen, Ph.D.

Published on :

WIB-Capital Region: Member Spotlight with Julie (Wu) Rosen, Ph.D. Tuesday, February 11, 2020 Tell us about your background (both educational and professional). I am an Assistant Professor in the Department of Obstetrics, Gynecology & Reproductive Sciences at the University of Maryland School of Medicine (UMSOM), and I serve as one of two Executive Directors for [….]

In Conversation: Dr. Harsha K. Rajasimha, IndoUSrare

Published on :

In Conversation: Dr. Harsha K. Rajasimha, IndoUSrare BioBuzz recently sat down for a conversation with Dr. Harsha K. Rajasimha, a leading rare disease advocate, the founder of the non-profit, IndoUSrare, and the CEO of Jeeva Informatics, a leading AI and digital health company focused on decentralized clinical trials.  February is Rare Disease Month. What does [….]

The Journey To Commercialization for a Novel Medical Device Startup: Q&A with Sonavex CEO, David Narrow

Published on :

The Journey To Commercialization for a Novel Medical Device Startup: Q&A with Sonavex CEO, David Narrow May 7, 2019 In the past year Sonavex has landed not one, but two FDA 510(k) clearances for their ultrasound-based medical devices. This first of its kind solution is comprised of two components, EchoMark and EchoSure, that use a [….]

Q&A with Virginia (Ginny) Espina, PhD, MT(ASCP)

Published on :

Q&A with Virginia (Ginny) Espina, PhD, MT(ASCP) Dr. Ginny Espina is a Research Associate Professor at George Mason University’s Center for Applied Proteomics and Molecular Medicine. She will be the Workshop Director for the upcoming Bio-TracⓇ Symposium, “Laser Microdissection: From Biology to Immuno-Oncology” that runs from March 4-8, 2019. ______ The BioBuzz team had the [….]

Q&A with Joseph Bressler, Ph.D.

Published on :

Q&A with Joseph Bressler, Ph.D., Research Scientist at Kennedy Krieger Institute January 29, 2019 Dr. Joseph Bressler is a research scientist at Kennedy Krieger Institute. He is also an associate professor of environmental health sciences at the Bloomberg School of Public Health at Johns Hopkins University. His research focuses on delineating responses to environmental agents [….]

Q&A with Jaime Rodriguez-Canales, M.D., FEBP – The importance of Multiplex Immunofluorescence in the field of Immune-Oncology

Published on :

Q&A with Jaime Rodriguez-Canales, M.D., FEBP Dr. Rodriguez-Canales is a Senior Pathologist at MedImmune, and Course Director for the recent Multiplex Immunofluorescence in Immune-Oncology Symposium, a Bio-Trac program cosponsored by Medimmune & PerkinElmer (now Akoya Biosciences). After a successful first annual Symposium and Workshop, we had the opportunity to catch up with Course Director, Dr. [….]

Q&A With BeneVir Co-Founder, Katherine Sacksteder, PhD – The Path to a Landmark Acquisition (Part 1)

Published on :

Q&A With BeneVir Co-Founder and COO, Katherine Sacksteder, PhD – The Path to a Landmark Acquisition (Part 1) October 9, 2018 This has been a year marked by many notable biotech deals, especially in the immunotherapy market.  One deal, in particular, has generated more local excitement in the BioHealth Capital Region than any other; that is [….]

Abhita Batra, Otomagnetics CEO, Aims to Change the Lives of Childhood Cancer Survivors with Magnetic Drug Delivery Technology

Published on :

Abhita Batra, Otomagnetics CEO, Aims to Change the Lives of Childhood Cancer Survivors with Magnetic Drug Delivery Technology October 8, 2018 Abhita Batra, CEO Otomagnetics, Inc., is leading the growth of an innovative biotech startup, and bringing a drug delivery technology to market that could change the lives of childhood cancer survivors.  As with many [….]